Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Radiation × 30 days × Clear all

Sponsor

Conditions

Lung Neoplasms 6 Oropharyngeal Neoplasms 5 Glioblastoma 5 Urinary Bladder Neoplasms 4 Prostatic Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 4 Mouth Neoplasms 3 Laryngeal Neoplasms 3 Glioma 3 Carcinoma 3 Astrocytoma 3 Vaginal Neoplasms 2 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Rhabdomyosarcoma, Embryonal 2 Rhabdomyosarcoma 2 Liposarcoma 2 Leiomyosarcoma 2 Hypopharyngeal Neoplasms 2 Histiocytoma, Malignant Fibrous 2 Ependymoma 2 Burkitt Lymphoma 2 Adenocarcinoma of Lung 2 Wilms Tumor 1 Triple Negative Breast Neoplasms 1 Teratoma 1 Sinonasal undifferentiated carcinoma 1 Sinonasal Squamous Cell Carcinoma 1

Interventions

Cyclophosphamide 12 Rituximab 11 obinutuzumab 9 fludarabine 9 Prednisone 7 ibrutinib 6 Lenalidomide 6 tocilizumab 5 fludarabine phosphate 5 Biopsy 5 venetoclax 4 pirtobrutinib 4 glofitamab 4 Specimen Handling 4 Doxorubicin 4 polatuzumab vedotin 3 X-Rays 3 Vincristine 3 Phantoms, Imaging 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 tucatinib 2 temsirolimus 2 pertuzumab 2 palbociclib 2 olaparib 2 cobimetinib 2 Whole-Body Irradiation 2 Vemurafenib 2 Trastuzumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡